Insider Transactions in Q1 2022 at Ionis Pharmaceuticals Inc (IONS)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2022
|
C Frank Bennett EVP, Chief Scientific Officer |
BUY
Other acquisition or disposition
|
Direct |
346
+0.62%
|
$9,688
$28.37 P/Share
|
|
Feb 28
2022
|
Richard S Geary EVP, Chief Development Officer |
BUY
Other acquisition or disposition
|
Direct |
621
+1.09%
|
$17,388
$28.37 P/Share
|
|
Feb 28
2022
|
Elizabeth L Hougen EVP, Finance & CFO |
BUY
Other acquisition or disposition
|
Direct |
384
+0.65%
|
$10,752
$28.37 P/Share
|
|
Feb 28
2022
|
Brett P Monia Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
621
+0.69%
|
$17,388
$28.37 P/Share
|
|
Feb 28
2022
|
Patrick R. O'Neil EVP CLO & General Counsel |
BUY
Other acquisition or disposition
|
Direct |
735
+1.75%
|
$20,580
$28.37 P/Share
|
|
Feb 28
2022
|
Eric Swayze EVP Research |
BUY
Other acquisition or disposition
|
Direct |
621
+2.91%
|
$17,388
$28.37 P/Share
|
|
Jan 26
2022
|
Brett P Monia Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,032
-8.33%
|
$248,992
$31.44 P/Share
|
|
Jan 26
2022
|
Brett P Monia Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,198
+7.64%
|
-
|
|
Jan 18
2022
|
Eric Swayze EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
4,994
-19.89%
|
$149,820
$30.12 P/Share
|
|
Jan 18
2022
|
Eric Swayze EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
13,809
+35.49%
|
-
|
|
Jan 18
2022
|
Eugene Schneider EVP, Chf Clinical Develop Ofcr |
SELL
Payment of exercise price or tax liability
|
Direct |
3,815
-21.71%
|
$114,450
$30.12 P/Share
|
|
Jan 18
2022
|
Eugene Schneider EVP, Chf Clinical Develop Ofcr |
BUY
Exercise of conversion of derivative security
|
Direct |
10,400
+37.18%
|
-
|
|
Jan 18
2022
|
Richard S Geary EVP, Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,605
-12.0%
|
$228,150
$30.12 P/Share
|
|
Jan 18
2022
|
Richard S Geary EVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,391
+25.24%
|
-
|
|
Jan 18
2022
|
Brett P Monia Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,714
-19.73%
|
$591,420
$30.12 P/Share
|
|
Jan 18
2022
|
Brett P Monia Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
49,475
+33.11%
|
-
|
|
Jan 18
2022
|
Elizabeth L Hougen EVP, Finance & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,828
-11.9%
|
$234,840
$30.12 P/Share
|
|
Jan 18
2022
|
Elizabeth L Hougen EVP, Finance & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,050
+25.1%
|
-
|
|
Jan 18
2022
|
Patrick R. O'Neil EVP CLO & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
7,501
-15.6%
|
$225,030
$30.12 P/Share
|
|
Jan 18
2022
|
Patrick R. O'Neil EVP CLO & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
21,086
+30.48%
|
-
|
|
Jan 18
2022
|
C Frank Bennett EVP, Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,726
-10.92%
|
$201,780
$30.12 P/Share
|
|
Jan 18
2022
|
C Frank Bennett EVP, Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,842
+23.42%
|
-
|
|
Jan 18
2022
|
Onaiza Cadoret Manier EVP, Chf GL Pdt Str & Oper Ofc |
SELL
Payment of exercise price or tax liability
|
Direct |
2,305
-21.57%
|
$69,150
$30.12 P/Share
|
|
Jan 18
2022
|
Onaiza Cadoret Manier EVP, Chf GL Pdt Str & Oper Ofc |
BUY
Exercise of conversion of derivative security
|
Direct |
6,057
+36.17%
|
-
|
|
Jan 18
2022
|
B Lynne Parshall Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,652
-2.09%
|
$49,560
$30.12 P/Share
|
|
Jan 18
2022
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,754
+6.78%
|
-
|